Reversing liver fibrosis and cirrhosis, traditional Chinese medicine has obvious advantages!

Counts:6392021-11-19 14:19:09　 Source:Take good care of each other

In order to further strengthen and standardize the diagnosis and treatment practice and improve the diagnosis and treatment level of infectious diseases and liver diseases, the "11th Beijing infectious diseases and Liver Diseases Forum" co sponsored by Beijing Doctors Association, infection specialist branch of Beijing Doctors Association and the first hospital of Peking University was held in Beijing from May 18 to 20, 2018.
Can hepatic fibrosis and cirrhosis really be reversed?

On the afternoon of the 19th, academician Zhuang Hui of the Chinese Academy of engineering, Professor Wang GuiQiang of the first hospital of Peking University, Professor Lv Fudong of Beijing You'an Hospital Affiliated to Capital Medical University, Professor Wang Rongbing of Beijing Ditan hospital and Professor Wei Lai of Peking University People's Hospital gathered together to launch a wonderful academic storm on this content. Take care of each other sincerely, and the platform will webcast this symposium.

The conference was presided over by academician Zhuang Hui. First, Professor Wang Guiqiang introduced the national "12th Five-Year" special topic, which was led by him. It adopted a multi center (54 hospitals) and a large sample (2000 cases). It is the first time for hepatitis B patients with liver fibrosis. Control test.

The research results show that antiviral treatment is the key to control the progress of chronic hepatitis B treatment, and can effectively reduce the incidence of liver cirrhosis and HCC; However, the control of antiviral therapy on the progression of liver fibrosis is still not satisfactory, and anti fibrosis drugs need to be studied; Anluohuaxian pill has good clinical research evidence as a drug for liver fibrosis.
Professor Wang GuiQiang will continue to verify the data in the future major scientific and technological special research of the 13th five year plan. If the results are clear, he will carry out clinical promotion.
Subsequently, Professor Lv Fudong of Beijing You'an Hospital Affiliated to Capital Medical University made a report on "reversal and interpretation of liver cirrhosis", comprehensively analyzing the morphological changes of liver cirrhosis reversal from the perspective of pathology.
Professor Wei Lai of the people's Hospital of Peking University congratulated Anluohuaxian Pill on its good advantages in patients with liver puncture baseline ≥ 4, and congratulated Professor Wang GuiQiang on deepening this research in the 13th five year plan. Professor Wei Lai mentioned that based on the current samples, further research can be carried out on which pathological features of traditional Chinese medicine effective for chronic hepatitis B, such as Anluohuaxian pill, have the best curative effect, so as to facilitate clinicians to choose drugs. Domestic anti fibrosis drugs have been widely concerned. At present, there is no drug that can well reverse liver fibrosis, especially hepatitis C. If you can, it is also very valuable to continue to explore the drug effect of patients with hepatitis C.

Professor Wang Rongbing of Beijing Ditan Hospital mentioned that the team led by Professor Wang GuiQiang used traditional Chinese medicine and antiviral drugs in combination, which had a significant reversal effect on patients with liver fibrosis or early liver cirrhosis with a baseline of ≥ 4. The control of the two groups reached 24%, which was very exciting, and it was also a comfort to the experts who first introduced the concept of liver fibrosis in our country. Antiviral etiology treatment determines the inhibition of liver fibrosis, and without antiviral treatment, liver fibrosis drugs are also playing a role. Therefore, liver fibrosis drugs will play a series of roles in alcoholic liver disease, autoimmune liver disease, nonalcoholic liver disease and other liver diseases in the future. It also requires the efforts of doctors to further excavate and do better the products derived from Chinese intellectual property rights.

Professor Lv Fudong mentioned that in the major special research of Professor Wang GuiQiang in the 12th Five Year Plan, the pathology part was undertaken by Beijing You'an Hospital. The pathology center made unified staining, unified production, double-blind reading of films, scored respectively, and scored from the two aspects of inflammation and fibrosis. The process was very rigorous.

Professor Wang GuiQiang finally added: many experts are studying the major special topic anti fibrosis treatment. A series of anti fibrosis drugs are being developed internationally, focusing on different targets and diseases. In our country, they are based on Chinese patent medicines. Major special research can indeed tap the treasure house of medicine in the motherland. Previously, academician Zhuang Hui's team also did a very excellent work, that is, the mechanism research of Anluo chemical fiber pill. The anti fibrosis effect can be seen from the animal model, which is also consistent with the clinic. However, our clinical data are still limited, so the research of major special projects in the 13th five year plan will expand the sample size for verification.

Academician Zhuang Hui finally concluded that the view that antiviral therapy can reverse liver fibrosis was still controversial in 2014, but it has been confirmed that antiviral therapy plus traditional Chinese medicine can reverse liver cirrhosis. Simple antiviral treatment can also reverse liver cirrhosis, but it is far from enough. After adding traditional Chinese medicine, the reversal of liver fibrosis is more obvious. This result is credible and excellent.

This is unique to China. We need to further expand the sample and further study it in the 13th five year plan. Future research should be used not only for hepatitis B but also for hepatitis C. How to use anti fibrosis drugs to cure patients after antiviral treatment is a very important research.
Traditional Chinese medicine is a treasure house of wisdom inherited by the motherland for a long time and should be used reasonably. In recent years, there are more and more studies on the treatment of liver fibrosis by traditional Chinese medicine, and the unique advantages of traditional Chinese medicine are becoming more and more obvious. At present, the control of antiviral therapy on the progress of liver fibrosis is still not ideal. The research and development of anti fibrosis drugs has become a hot spot in the field of liver disease treatment. I believe that with the full cooperation of the majority of peers, China's progress in anti hepatic fibrosis treatment will make more achievements! (treating each other with sincerity - online public service platform for hepatobiliary diseases www.igandan. Com)